Actimed Therapeutics Closes Over-Subscribed Series A Financing Round Of £5 Million To Advance Clinical Development Of Lead Programme For Cancer Cachexia
Round Type
Series A
AscotBiotechnologyHealth CareMedicalTherapeuticsDescription
London, UK – 26 June 2023. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, announces that it has raised over £5 million in an over-subscribed Series A financing round. This investment will support the development of the Actimed pipeline, including S-pindolol benzoate, with preparations under way for a Phase 2b/3 programme (the “IMPACT” programme) targeted at the treatment of cancer cachexia in non-small cell lung cancer and colorectal cancer.
Quick answer
Actimed Therapeutics raised an undisclosed amount in a Series A round, dated June 26, 2023. Actimed Therapeutics is based in Ascot, Berkshire, United Kingdom.
- How much did Actimed Therapeutics raise?
- Actimed Therapeutics raised an undisclosed amount in a Series A round on June 26, 2023.
- What does Actimed Therapeutics do?
- Actimed Therapeutics is a clinical stage speciality pharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient..
- Where is Actimed Therapeutics based and how big is it?
- Actimed Therapeutics is based in Ascot, Berkshire, United Kingdom. Fundz records about 10 employees.
- Who are the decision-makers at Actimed Therapeutics?
- Fundz holds 1 contact at Actimed Therapeutics, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Actimed Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Ikena Oncology raised $43M on August 4, 2023.
- Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
- Actym Therapeutics raised $11M on June 28, 2023.
- Qnovia raised $2.9M on May 25, 2023.
- Renibus Therapeutics raised $64M on May 25, 2023.
- Alltrna raised an undisclosed amount (Series B) on August 9, 2023.
Who to call at Actimed Therapeutics, and when
A new round usually means Actimed Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Actimed Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Actimed Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actimed Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actimed Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansActimed Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.